Matrix metalloproteinase 2 and membrane type 1 matrix metalloproteinase co-regulate axonal outgrowth of mouse retinal ganglion cells

Journal of Neurochemistry

Volumn 129, Issue 6, 2014, Pages 966-979

  Gaublomme, Djoere ^a   Buyens, Tom ^a   De Groef, Lies ^a   Stakenborg, Michelle ^a   Janssens, Els ^a   Ingvarsen, Signe ^b,c   Porse, Astrid ^b   Behrendt, Niels ^b   Moons, Lieve ^a  

^a SKELETAL BIOLOGY AND ENGINEERING RESEARCH CENTER   (Belgium)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c NOVO NORDISK A S   (Denmark)

Author keywords

axon outgrowth; explant; integrin; matrix metalloproteinase (MMP); retina; retinal ganglion cell (RGC)

Indexed keywords

BETA1 INTEGRIN; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE 14;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL SURFACE; COMPLEX FORMATION; CONTROLLED STUDY; GLIA CELL; MOUSE; NERVE FIBER GROWTH; NERVE FIBER MEMBRANE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RETINA GANGLION CELL;

MAMMALIA; MUS;

AXON OUTGROWTH; EXPLANT; INTEGRIN; MATRIX METALLOPROTEINASE (MMP); RETINA; RETINAL GANGLION CELL (RGC);

ANIMALS; ANTIBODIES, BLOCKING; ANTIGENS, CD29; AXONS; GELATINASES; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASE INHIBITORS; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; ORGAN CULTURE TECHNIQUES; RETINAL GANGLION CELLS; SIGNAL TRANSDUCTION;

EID: 84902381536     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12703     Document Type: Article

References (58)

1. Agapova O. A., Ricard C. S., Salvador-Silva M., and, Hernandez M. R., (2001) Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human optic nerve head astrocytes. Glia 33, 205-216.
2. Agapova O. A., Kaufman P. L., Lucarelli M. J., Gabelt B. T., and, Hernandez M. R., (2003) Differential expression of matrix metalloproteinases in monkey eyes with experimental glaucoma or optic nerve transection. Brain Res. 967, 132-143.
3. Ahmed Z., Dent R. G., Leadbeater W. E., Smith C., Berry M., and, Logan A., (2005) Matrix metalloproteases: degradation of the inhibitory environment of the transected optic nerve and the scar by regenerating axons. Mol. Cell. Neurosci. 28, 64-78.
4. Bates C. A., and, Meyer R. L., (1997) The neurite-promoting effect of laminin is mediated by different mechanisms in embryonic and adult regenerating mouse optic axons in vitro. Dev. Biol. 181, 91-101.
5. Busch S. A., Horn K. P., Silver D. J., and, Silver J., (2009) Overcoming macrophage-mediated axonal dieback following CNS injury. J. Neurosci. 29, 9967-9976.
6. Cauwe B., and, Opdenakker G., (2010) Intracellular substrate cleavage: a novel dimension in the biochemistry, biology and pathology of matrix metalloproteinases. Crit. Rev. Biochem. Mol. Biol. 45, 351-423.
7. Chintala S. K., Zhang X., Austin J. S., and, Fini M. E., (2002) Deficiency in matrix metalloproteinase gelatinase B (MMP-9) protects against retinal ganglion cell death after optic nerve ligation. J. Biol. Chem. 277, 47461-47468.
8. Choi D. H., Kim E. M., Son H. J., Joh T. H., Kim Y. S., Kim D., Flint Beal M., and, Hwang O., (2008) A novel intracellular role of matrix metalloproteinase-3 during apoptosis of dopaminergic cells. J. Neurochem. 106, 405-415.
9. Cua R. C., Lau L. W., Keough M. B., Midha R., Apte S. S., and, Yong V. W., (2013) Overcoming neurite-inhibitory chondroitin sulfate proteoglycans in the astrocyte matrix. Glia 61, 972-984.
10. Curtin M. L., Florjancic A. S., Heyman H. R., et al,. (2001) Discovery and characterization of the potent, selective and orally bioavailable MMP inhibitor ABT-770. Bioorg. Med. Chem. Lett. 11, 1557-1560.
11. Devy L., Huang L., Naa L., et al,. (2009) Selective inhibition of matrix metalloproteinase-14 blocks tumor growth, invasion, and angiogenesis. Cancer Res. 69, 1517-1526.
12. Ferguson T. A., and, Muir D., (2000) MMP-2 and MMP-9 increase the neurite-promoting potential of schwann cell basal laminae and are upregulated in degenerated nerve. Mol. Cell. Neurosci. 16, 157-167.
13. Galis Z. S., Kranzhofer R., Fenton J. W., 2nd, and, Libby P., (1997) Thrombin promotes activation of matrix metalloproteinase-2 produced by cultured vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 17, 483-489.
14. Gariano R. F., Hu D., and, Helms J., (2006) Expression of angiogenesis-related genes during retinal development. Gene Expr. Patterns 6, 187-192.
15. Gaublomme D., Buyens T., and, Moons L., (2012) Automated analysis of neurite outgrowth in mouse retinal explants. J. Biomol. Screen. 18, 534-543.
16. Giannelli G., Pozzi A., Stetler-Stevenson W. G., Gardner H. A., and, Quaranta V., (1999) Expression of matrix metalloprotease-2-cleaved laminin-5 in breast remodeling stimulated by sex steroids. Am. J. Pathol. 154, 1193-1201.
17. Goldberg J. L., Espinosa J. S., Xu Y., Davidson N., Kovacs G. T., and, Barres B. A., (2002a) Retinal ganglion cells do not extend axons by default: promotion by neurotrophic signaling and electrical activity. Neuron 33, 689-702.
18. Goldberg J. L., Klassen M. P., Hua Y., and, Barres B. A., (2002b) Amacrine-signaled loss of intrinsic axon growth ability by retinal ganglion cells. Science 296, 1860-1864.
19. Hayashita-Kinoh H., Kinoh H., Okada A., Komori K., Itoh Y., Chiba T., Kajita M., Yana I., and, Seiki M., (2001) Membrane-type 5 matrix metalloproteinase is expressed in differentiated neurons and regulates axonal growth. Cell Growth Differ. 12, 573-580.
20. Hehr C. L., Hocking J. C., and, McFarlane S., (2005) Matrix metalloproteinases are required for retinal ganglion cell axon guidance at select decision points. Development 132, 3371-3379.
21. Hernandez-Barrantes S., Toth M., Bernardo M. M., Yurkova M., Gervasi D. C., Raz Y., Sang Q. A., and, Fridman R., (2000) Binding of active (57 kDa) membrane type 1-matrix metalloproteinase (MT1-MMP) to tissue inhibitor of metalloproteinase (TIMP)-2 regulates MT1-MMP processing and pro-MMP-2 activation. J. Biol. Chem. 275, 12080-12089.
22. Hikita S. T., Cann G. M., Wingerd K. L., Mullick L. H., Wayne W. C., Webb S. W., and, Clegg D. O., (2003) Integrin alpha4beta1 (VLA-4) expression and activity in retinal and peripheral neurons. Mol. Cell. Neurosci. 23, 427-439.
23. Holmbeck K., Bianco P., Caterina J., et al,. (1999) MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell 99, 81-92.
24. Ingvarsen S., Porse A., Erpicum C., et al,. (2013) Targeting a single function of the multifunctional matrix metalloprotease MT1-MMP: impact on lymphangiogenesis. J. Biol. Chem. 288, 10195-10204.
25. Itoh T., Ikeda T., Gomi H., Nakao S., Suzuki T., and, Itohara S., (1997) Unaltered secretion of beta-Amyloid precursor protein in gelatinase A (matrix metalloproteinase 2)-deficient mice. J. Biol. Chem. 272, 22389-22392.
26. Janssens E., Gaublomme D., De Groef L., Darras V. M., Arckens L., Delorme N., Claes F., Van Hove I., and, Moons L., (2013) Matrix metalloproteinase 14 in the zebrafish: an eye on retinal and retinotectal development. PLoS ONE 8, e52915.
27. Kim E. M., Shin E. J., Choi J. H., Son H. J., Park I. S., Joh T. H., and, Hwang O., (2010) Matrix metalloproteinase-3 is increased and participates in neuronal apoptotic signaling downstream of caspase-12 during endoplasmic reticulum stress. J. Biol. Chem. 285, 16444-16452.
28. Kryczka J., Stasiak M., Dziki L., Mik M., Dziki A., and, Cierniewski C., (2012) Matrix metalloproteinase-2 cleavage of the beta1 integrin ectodomain facilitates colon cancer cell motility. J. Biol. Chem. 287, 36556-36566.
29. Levkau B., Kenagy R. D., Karsan A., Weitkamp B., Clowes A. W., Ross R., and, Raines E. W., (2002) Activation of metalloproteinases and their association with integrins: an auxiliary apoptotic pathway in human endothelial cells. Cell Death Differ. 9, 1360-1367.
30. Limb G. A., Daniels J. T., Pleass R., Charteris D. G., Luthert P. J., and, Khaw P. T., (2002) Differential expression of matrix metalloproteinases 2 and 9 by glial Muller cells: response to soluble and extracellular matrix-bound tumor necrosis factor-Alpha. Am. J. Pathol. 160, 1847-1855.
31. Lin K. T., Sloniowski S., Ethell D. W., and, Ethell I. M., (2008) Ephrin-B2-induced cleavage of EphB2 receptor is mediated by matrix metalloproteinases to trigger cell repulsion. J. Biol. Chem. 283, 28969-28979.
32. Loers G., Makhina T., Bork U., Dorner A., Schachner M., and, Kleene R., (2012) The interaction between cell adhesion molecule L1, matrix metalloproteinase 14, and adenine nucleotide translocator at the plasma membrane regulates L1-mediated neurite outgrowth of murine cerebellar neurons. J. Neurosci. 32, 3917-3930.
33. Manabe S., Gu Z., and, Lipton S. A., (2005) Activation of matrix metalloproteinase-9 via neuronal nitric oxide synthase contributes to NMDA-induced retinal ganglion cell death. Invest. Ophthalmol. Vis. Sci. 46, 4747-4753.
34. Masaki T., Sugiyama M., Matsuoka H., Abe N., Izumisato Y., Sakamoto A., and, Atomi Y., (2003) Coexpression of matrilysin and laminin-5 gamma2 chain may contribute to tumor cell migration in colorectal carcinomas. Dig. Dis. Sci. 48, 1262-1267.
35. Mechtersheimer S., Gutwein P., Agmon-Levin N., et al. (2001) Ectodomain shedding of L1 adhesion molecule promotes cell migration by autocrine binding to integrins. J. Cell Biol. 155, 661-673.
36. Menon B., Singh M., and, Singh K., (2005) Matrix metalloproteinases mediate beta-Adrenergic receptor-stimulated apoptosis in adult rat ventricular myocytes. Am. J. Physiol. Cell Physiol. 289, C168-C176.
37. Mongan M., Wang J., Liu H., Fan Y., Jin C., Kao W. Y., and, Xia Y., (2011) Loss of MAP3K1 enhances proliferation and apoptosis during retinal development. Development 138, 4001-4012.
38. Morrison C. J., Butler G. S., Bigg H. F., Roberts C. R., Soloway P. D., and, Overall C. M., (2001) Cellular activation of MMP-2 (gelatinase A) by MT2-MMP occurs via a TIMP-2-independent pathway. J. Biol. Chem. 276, 47402-47410.
39. Nguyen M., Arkell J., and, Jackson C. J., (2000) Activated protein C directly activates human endothelial gelatinase A. J. Biol. Chem. 275, 9095-9098.
40. Nordstrom L. A., Lochner J., Yeung W., and, Ciment G., (1995) The metalloproteinase stromelysin-1 (transin) mediates PC12 cell growth cone invasiveness through basal laminae. Mol. Cell. Neurosci. 6, 56-68.
41. Ogier C., Bernard A., Chollet A. M., Le Diguardher T., Hanessian S., Charton G., Khrestchatisky M., and, Rivera S., (2006) Matrix metalloproteinase-2 (MMP-2) regulates astrocyte motility in connection with the actin cytoskeleton and integrins. Glia, 54, 272-284.
42. Page-McCaw A., Ewald A. J., and, Werb Z., (2007) Matrix metalloproteinases and the regulation of tissue remodelling. Nat. Rev. Mol. Cell Biol. 8, 221-233.
43. Pastrana E., Moreno-Flores M. T., Gurzov E. N., Avila J., Wandosell F., and, Diaz-Nido J., (2006) Genes associated with adult axon regeneration promoted by olfactory ensheathing cells: a new role for matrix metalloproteinase 2. J. Neurosci. 26, 5347-5359.
44. Pittman R. N., and, Williams A. G., (1989) Neurite penetration into collagen gels requires Ca2+-dependent metalloproteinase activity. Dev. Neurosci. 11, 41-51.
45. Santos A. R., Corredor R. G., Obeso B. A., et al,. (2012) beta1 integrin-focal adhesion kinase (FAK) signaling modulates retinal ganglion cell (RGC) survival. PLoS ONE 7, e48332.
46. Seigel G. M., (1999) The golden age of retinal cell culture. Mol. Vis. 5, 4.
47. Sharma K., Selzer M. E., and, Li S., (2012) Scar-mediated inhibition and CSPG receptors in the CNS. Exp. Neurol. 237, 370-378.
48. Takano A., Hirata A., Inomata Y., Kawaji T., Nakagawa K., Nagata S., and, Tanihara H., (2005) Intravitreal plasmin injection activates endogenous matrix metalloproteinase-2 in rabbit and human vitreous. Am. J. Ophthalmol. 140, 654-660.
49. Vaillant C., Meissirel C., Mutin M., Belin M. F., Lund L. R., and, Thomasset N., (2003) MMP-9 deficiency affects axonal outgrowth, migration, and apoptosis in the developing cerebellum. Mol. Cell. Neurosci. 24, 395-408.
50. Verslegers M., Lemmens K., Van Hove I., and, Moons L., (2013) Matrix metalloproteinase-2 and -9 as promising benefactors in development, plasticity and repair of the nervous system. Prog. Neurobiol. 105, 60-78.
51. Visse R., and, Nagase H., (2003) Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ. Res. 92, 827-839.
52. Vu T. H., Shipley J. M., Bergers G., Berger J. E., Helms J. A., Hanahan D., Shapiro S. D., Senior R. M., and, Werb Z., (1998) MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93, 411-422.
53. Walker E. J., and, Rosenberg G. A., (2009) TIMP-3 and MMP-3 contribute to delayed inflammation and hippocampal neuronal death following global ischemia. Exp. Neurol. 216, 122-131.
54. Webber C. A., Hocking J. C., Yong V. W., Stange C. L., and, McFarlane S., (2002) Metalloproteases and guidance of retinal axons in the developing visual system. J. Neurosci. 22, 8091-8100.
55. Williams M. A., Pinon L. G., Linden R., and, Pinto L. H., (1990) The pearl mutation accelerates the schedule of natural cell death in the early postnatal retina. Exp. Brain Res. 82, 393-400.
56. Yong V. W., Power C., Forsyth P., and, Edwards D. R., (2001) Metalloproteinases in biology and pathology of the nervous system. Nat. Rev. Neurosci. 2, 502-511.
57. Zhang X., Cheng M., and, Chintala S. K., (2004) Kainic acid-mediated upregulation of matrix metalloproteinase-9 promotes retinal degeneration. Invest. Ophthalmol. Vis. Sci. 45, 2374-2383.
58. Zuo J., Ferguson T. A., Hernandez Y. J., Stetler-Stevenson W. G., and, Muir D., (1998) Neuronal matrix metalloproteinase-2 degrades and inactivates a neurite-inhibiting chondroitin sulfate proteoglycan. J. Neurosci. 18, 5203-5211.